199 related articles for article (PubMed ID: 37996600)
21. Involvement of Ca
Guo S; Shen Y; He G; Wang T; Xu D; Wen F
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28679649
[TBL] [Abstract][Full Text] [Related]
22. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
Ruggieri P; Mangino G; Fioretti B; Catacuzzeno L; Puca R; Ponti D; Miscusi M; Franciolini F; Ragona G; Calogero A
PLoS One; 2012; 7(10):e47825. PubMed ID: 23110108
[TBL] [Abstract][Full Text] [Related]
23. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
24. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
[TBL] [Abstract][Full Text] [Related]
25. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
Toyama K; Wulff H; Chandy KG; Azam P; Raman G; Saito T; Fujiwara Y; Mattson DL; Das S; Melvin JE; Pratt PF; Hatoum OA; Gutterman DD; Harder DR; Miura H
J Clin Invest; 2008 Sep; 118(9):3025-37. PubMed ID: 18688283
[TBL] [Abstract][Full Text] [Related]
26. A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.
Turner KL; Honasoge A; Robert SM; McFerrin MM; Sontheimer H
Glia; 2014 Jun; 62(6):971-81. PubMed ID: 24585442
[TBL] [Abstract][Full Text] [Related]
27. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
28. KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.
Brown BM; Pressley B; Wulff H
Curr Neuropharmacol; 2018; 16(5):618-626. PubMed ID: 28676010
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of KCa3.1 K(+) channel in mesenteric lymph node CD4(+) T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease.
Ohya S; Fukuyo Y; Kito H; Shibaoka R; Matsui M; Niguma H; Maeda Y; Yamamura H; Fujii M; Kimura K; Imaizumi Y
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G873-85. PubMed ID: 24674776
[TBL] [Abstract][Full Text] [Related]
30. KCa3.1 modulates neuroblast migration along the rostral migratory stream (RMS) in vivo.
Turner KL; Sontheimer H
Cereb Cortex; 2014 Sep; 24(9):2388-400. PubMed ID: 23585521
[TBL] [Abstract][Full Text] [Related]
31. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
32. K
Mohr CJ; Gross D; Sezgin EC; Steudel FA; Ruth P; Huber SM; Lukowski R
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31480522
[TBL] [Abstract][Full Text] [Related]
33. K
Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
[TBL] [Abstract][Full Text] [Related]
34. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration.
Shao Z; Makinde TO; Agrawal DK
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):962-8. PubMed ID: 21493782
[TBL] [Abstract][Full Text] [Related]
35. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Stoneking CJ; Shivakumar O; Thomas DN; Colledge WH; Mason MJ
Am J Physiol Cell Physiol; 2013 May; 304(9):C858-72. PubMed ID: 23407879
[TBL] [Abstract][Full Text] [Related]
36. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
38. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
Yi M; Dou F; Lu Q; Yu Z; Chen H
Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
[TBL] [Abstract][Full Text] [Related]
39. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM
Diabetes; 2013 Aug; 62(8):2923-34. PubMed ID: 23656889
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]